Ledell Jebediah 4
4 · AVEO PHARMACEUTICALS, INC. · Filed Jan 19, 2023
Insider Transaction Report
Form 4
Ledell Jebediah
Chief Operating Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-01-19−27,702→ 0 totalExercise: $3.67Exp: 2032-02-15→ Common Stock (27,702 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-01-19−170,000→ 0 totalExercise: $5.92Exp: 2031-12-01→ Common Stock (170,000 underlying)
Footnotes (1)
- [F1]This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes.